| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
5,524,000 |
| Market
Cap: |
570.02(M) |
| Last
Volume: |
19,542 |
Avg
Vol: |
40,496 |
| 52
Week Range: |
$84.55 - $168.51 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
1,500 |
10,500 |
46,373 |
| Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$8,243,267 |
| Total People Sold |
0 |
1 |
3 |
8 |
| Total Sell Transactions |
0 |
1 |
5 |
25 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sullivan John James |
Director |
– • – |
2020-12-01 |
4 |
AS |
$275.22 |
$344,025 |
D/D |
(1,250) |
61,708 |
|
-8% |
|
| Sakys John V |
CFO |
• – – |
2020-11-17 |
4 |
AS |
$290.00 |
$285,360 |
D/D |
(984) |
3,350 |
|
-15% |
|
| Sakys John V |
CFO |
• – – |
2020-11-17 |
4 |
OE |
$89.70 |
$88,265 |
D/D |
984 |
4,334 |
|
- |
|
| Kelly David M |
Director |
– • – |
2020-11-16 |
4 |
S |
$283.31 |
$199,450 |
D/D |
(704) |
2,600 |
|
15% |
|
| Kelly David M |
Director |
– • – |
2020-11-16 |
4 |
OE |
$58.51 |
$995 |
D/D |
17 |
3,304 |
|
- |
|
| Hall Shannon |
Director |
– • – |
2020-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
254 |
254 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2020-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
477 |
36,355 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2020-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
477 |
62,958 |
|
- |
|
| Kelly David M |
Director |
– • – |
2020-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
477 |
3,287 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2020-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
477 |
73,944 |
|
- |
|
| Alltoft Jennifer Sadie |
Director |
– • – |
2020-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
477 |
686 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2020-11-13 |
4 |
S |
$274.30 |
$562,315 |
D/D |
(2,050) |
35,878 |
|
13% |
|
| Guillemin Evan |
Director |
– • – |
2020-11-13 |
4 |
OE |
$29.20 |
$85,690 |
D/D |
2,050 |
37,928 |
|
- |
|
| Guillemin Evan |
Director |
• • – |
2020-11-12 |
4 |
S |
$273.77 |
$260,082 |
D/D |
(950) |
35,878 |
|
11% |
|
| Guillemin Evan |
Director |
• • – |
2020-11-12 |
4 |
OE |
$29.20 |
$45,860 |
D/D |
950 |
36,828 |
|
- |
|
| Sullivan John James |
Director |
• • – |
2020-11-11 |
4 |
S |
$272.36 |
$340,450 |
D/D |
(1,250) |
62,481 |
|
10% |
|
| Archbold Brian David |
SVP Continuous Improvement |
• – – |
2020-11-09 |
4 |
S |
$272.11 |
$145,035 |
D/D |
(533) |
232 |
|
9% |
|
| Archbold Brian David |
SVP Continuous Improvement |
• – – |
2020-11-09 |
4 |
OE |
$203.54 |
$108,487 |
D/D |
533 |
765 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2020-10-08 |
4 |
AS |
$276.90 |
$260,840 |
D/D |
(942) |
3,350 |
|
-1% |
|
| Sakys John V |
CFO |
• – – |
2020-10-08 |
4 |
OE |
$89.70 |
$84,497 |
D/D |
942 |
4,292 |
|
- |
|
| Owens Gary M |
President and CEO |
• – – |
2020-10-08 |
4 |
AS |
$276.91 |
$89,442 |
D/D |
(323) |
9,863 |
|
-1% |
|
| Owens Gary M |
President and CEO |
• – – |
2020-10-07 |
4 |
AS |
$275.00 |
$186,175 |
D/D |
(677) |
10,186 |
|
2% |
|
| Owens Gary M |
President and CEO |
• – – |
2020-10-06 |
4 |
AS |
$265.00 |
$265,000 |
D/D |
(1,000) |
10,863 |
|
5% |
|
| Dinoia Gregory |
SVP Commercial |
• • – |
2020-10-02 |
4 |
AS |
$260.00 |
$86,320 |
D/D |
(332) |
1,120 |
|
11% |
|
| Dinoia Gregory |
SVP Commercial |
• • – |
2020-10-02 |
4 |
OE |
$142.40 |
$38,448 |
D/D |
270 |
1,452 |
|
- |
|
176 Records found
|
|
Page 6 of 8 |
|
|
1.39 (1.37%) 
